This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.
Clinical trial NCT03156114 · COMPLETED
Trial details
- NCT number
- NCT03156114
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2023-03-09
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.